Lung Injury Clinical Trials

A listing of Lung Injury medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

California

Fresno California 93701

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

Torrance California 90509

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

Florida

Jacksonville Florida 32209

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

Illinois

Chicago Illinois 60611

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

Springfield Illinois 62702

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

Kansas

Topeka Kansas 66604

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

Kentucky

Hazard Kentucky 41701

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

Louisiana

New Orleans Louisiana 70112

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

Massachusetts

Boston Massachusetts 02115

A clinical study for patients with Respiratory Failure, Acute Respiratory Distress Syndrome or Acute Lung Injury

Missouri

Columbia Missouri 65212

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

Nebraska

Omaha Nebraska 68198

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

Omaha Nebraska 68131

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

Nevada

Las Vegas Nevada 89109

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

New York

Bronx New York 10467-2490

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

Buffalo New York 14215

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

Syracuse New York 13210

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

Ohio

Cleveland Ohio 44111

A clinical research study of Oxepa and Jevity 1.5 for the treatment of Acute Lung Injury, Mechanical Ventilation Complication or Dietary Modification

Cleveland Ohio 44195

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

Columbus Ohio 43210

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

Lima Ohio 45801

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

Australia

North Ryde

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

Belgium

Brussels

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

Canada

Kirkland Quebec H9H 3L1

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

China

Beijing 100071

A clinical trial to evaluate treatments using UCMSC group and Control group (Normal saline) for patients with Paraquat Poisoning or Lung Injury

Beijing 100071

A clinical trial to evaluate treatments using UCMSC group for patients with Acute Lung Injury or Acute Respiratory Distress Syndrome

Hangzhou Zhejiang 310003

A clinical trial seeking patients for a research study for the treatment of Acute Lung Injury, Acute Respiratory Distress Syndrome (ARDS) or Multiple Organ Failure

Croatia

Zagreb

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

Czech Republic

Praha

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

Estonia

Tallinn

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

Georgia

Tbilisi

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

Greece

Alimos

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

Hungary

Budapest

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

Korea, Republic of

Seoul 4130

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

Latvia

Riga

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

Lebanon

Beirut

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

New Zealand

Wellington

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

Philippines

Makati

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

Russian Federation

Moscow

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

Serbia

Belgrade

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

Slovakia

Bratislava

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

Spain

Madrid

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

Ukraine

Kiev

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

United Kingdom

Birmingham B9 5SS

Patients are needed to participate in a clinical research study evaluating GSK2862277 and Placebo for the treatment of Lung Injury, Acute and Respiratory Distress Syndrome, Adult

Birmingham B15 2TH

Patients are needed to participate in a clinical research study evaluating GSK2862277 and Placebo for the treatment of Lung Injury, Acute and Respiratory Distress Syndrome, Adult

Middlesborough TS4 3BU

Patients are needed to participate in a clinical research study evaluating GSK2862277 and Placebo for the treatment of Lung Injury, Acute and Respiratory Distress Syndrome, Adult